488 Participants Needed

Telephone Support for Advanced Gastrointestinal Cancer

Recruiting at 3 trial locations
HM
Overseen ByHannah Mullin
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Indiana University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It seems focused on telephone support rather than medication changes.

What data supports the effectiveness of the treatment Telephone Support Program, Telephone Counseling Program, Telephone-Based Acceptance and Commitment Therapy (ACT), Education/Support Program for advanced gastrointestinal cancer?

Research shows that Acceptance and Commitment Therapy (ACT), which is part of the telephone support program, can help reduce pain, depressive symptoms, and sleep disturbances in patients and caregivers dealing with advanced gastrointestinal cancer. Although the study did not find significant differences between groups, patients and caregivers who received ACT experienced moderate improvements in these areas.12345

Is telephone-based Acceptance and Commitment Therapy (ACT) safe for humans?

Research on telephone-based Acceptance and Commitment Therapy (ACT) for advanced gastrointestinal cancer patients and caregivers suggests it is safe, as no significant adverse effects were reported. It may even help reduce symptoms like pain, depression, sleep disturbances, and anxiety.13678

How is the Telephone Support Program for advanced gastrointestinal cancer different from other treatments?

The Telephone Support Program uses Acceptance and Commitment Therapy (ACT) delivered over the phone, which is unique because it focuses on helping patients and caregivers accept difficult emotions and commit to personal values, rather than trying to eliminate symptoms. This approach is novel for advanced gastrointestinal cancer as it addresses both patient and caregiver needs through a convenient, remote format.23579

What is the purpose of this trial?

The goal of this clinical trial is to see if telephone support programs help patients and their family caregivers adjust to advanced gastrointestinal cancer. A new telephone counseling program that involves practicing strategies for managing stress and symptoms will be compared to a telephone program involving education on quality-of-life issues and psychosocial support. The main questions it aims to answer are:Does our telephone counseling program lower the negative impact of patients' fatigue on their activities, emotions, and thinking abilities compared to a telephone program involving education and support? Does our telephone counseling program lower family caregivers' feelings of burden compared to a telephone program involving education and support?Participants in both study conditions will:Complete 6 weekly telephone sessions of counseling or education/support Complete a telephone booster session Complete 3 telephone interviews over about 5 months

Research Team

CE

Catherine E Mosher, Ph.D.

Principal Investigator

Indiana University Indianapolis

Eligibility Criteria

This trial is for patients with advanced gastrointestinal cancer and their family caregivers. Participants must be willing to engage in weekly telephone sessions and interviews over approximately 5 months. Specific eligibility criteria are not provided, but typically include factors like age, health status, and the stage of cancer.

Inclusion Criteria

Family caregiver identified by a gastrointestinal cancer patient who meets the eligibility criteria
Patient can speak and read English
Caregiver has significant caregiving burden
See 5 more

Exclusion Criteria

My caregiver cannot participate due to hearing impairment.
I can do only a little activity daily.
I am currently receiving hospice care.
See 7 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks

Baseline Assessment

Participants complete a 35-minute individual phone assessment at baseline

1 week
1 phone assessment

Treatment

Participants receive six weekly 50-minute telephone sessions of either ACT or education/support

6 weeks
6 phone sessions

Booster Session

Participants complete a 30-minute booster phone session one month after the 2-week follow-up

1 session
1 phone session

Follow-up

Participants are monitored for outcomes at 2 weeks and 3 months post-intervention

3 months
3 phone interviews

Treatment Details

Interventions

  • Telephone Support Program
Trial Overview The study compares two types of telephone support: one offers counseling with stress management strategies (Acceptance and Commitment Therapy), while the other provides education on quality-of-life issues. The aim is to see which program better reduces patient fatigue impact and caregiver burden.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Acceptance and Commitment TherapyExperimental Treatment1 Intervention
Across six weekly 50-minute sessions and a booster session, advanced gastrointestinal cancer patients and caregivers practice various mindfulness exercises, clarify their values, and set specific goals in alignment with their values. Through in-session and home practice of skills, participants learn new and more adaptive ways to respond to unwanted internal experiences (e.g., fatigue, distress). Participants receive handouts on session topics and a compact disc (CD) that the team developed to guide mindfulness practices.
Group II: Education/SupportActive Control1 Intervention
Across six weekly 50-minute sessions and a booster session, advanced gastrointestinal cancer patients and caregivers are directed to resources for practical and health information and contact information for psychosocial services. Sessions include an orientation to the patient's medical center and treatment team, education regarding common quality-of-life concerns experienced by cancer patients and caregivers, and an overview of medical center and community resources for addressing these concerns. The therapist also describes resources for addressing financial concerns and methods of evaluating health information available via the Internet and other modalities. Participants receive handouts summarizing session topics and are asked to review them as homework.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Indiana University

Lead Sponsor

Trials
1,063
Recruited
1,182,000+

National Cancer Institute (NCI)

Collaborator

Trials
14,080
Recruited
41,180,000+

Northwestern University

Collaborator

Trials
1,674
Recruited
989,000+

M.D. Anderson Cancer Center

Collaborator

Trials
3,107
Recruited
1,813,000+

Eskenazi Health

Collaborator

Trials
14
Recruited
3,700+

Findings from Research

Acceptance and Commitment Therapy (ACT) is a promising psychological intervention that helps terminally ill cancer patients manage physical, psychological, and social challenges, ultimately enhancing their quality of life.
There is strong evidence from international studies supporting the effectiveness of ACT in improving health-related outcomes for patients, caregivers, and healthcare professionals, highlighting the need for further research in South Korea's hospice and palliative care settings.
Application of Acceptance and Commitment Therapy (ACT) in Hospice and Palliative Care Settings.Park, SY.[2023]
A pilot study involving 25 cancer patients tested an Acceptance and Commitment Therapy (ACT) group intervention, showing promising results in reducing fear of progression, depression, and psychological inflexibility, while improving psychological health-related quality of life and well-being.
The high adherence rate among participants suggests that the ACT-based intervention is feasible for use in outpatient settings, although further research with randomized controlled trials is needed to confirm its effectiveness.
[Development and Evaluation of an Acceptance and Commitment Therapy (ACT)-Based Group Intervention for Cancer Patients with Psychological Burden].Sauer, C., Maatouk, I.[2022]
In a pilot study involving 40 patient-caregiver dyads with advanced gastrointestinal cancer, telephone-based acceptance and commitment therapy (ACT) showed feasibility and led to moderate reductions in pain severity and depressive symptoms for patients at 2 weeks and 3 months post-intervention.
Caregivers also benefited from ACT, experiencing moderate reductions in sleep disturbances and cognitive concerns, suggesting that this intervention may effectively address the symptom burden for both patients and their caregivers.
Impact of acceptance and commitment therapy on physical and psychological symptoms in advanced gastrointestinal cancer patients and caregivers: Secondary results of a pilot randomized trial.Burns, MF., Secinti, E., Johns, SA., et al.[2023]

References

Application of Acceptance and Commitment Therapy (ACT) in Hospice and Palliative Care Settings. [2023]
[Development and Evaluation of an Acceptance and Commitment Therapy (ACT)-Based Group Intervention for Cancer Patients with Psychological Burden]. [2022]
Impact of acceptance and commitment therapy on physical and psychological symptoms in advanced gastrointestinal cancer patients and caregivers: Secondary results of a pilot randomized trial. [2023]
Acceptance and commitment therapy in adult cancer survivors: a systematic review and conceptual model. [2023]
Can Acceptance & Commitment Therapy be delivered with fidelity as a brief telephone-intervention? [2021]
Symptom experiences in post-treatment cancer survivors: associations with acceptance and commitment therapy constructs. [2022]
Full-scale Randomized Trial Comparing Acceptance and Commitment Therapy Telephone-Delivered Coaching With Standard Telephone-Delivered Coaching Among Medicare/Uninsured Quitline Callers. [2023]
Efficacy of a self-management program on quality of life in colorectal cancer patients: A randomized controlled trial. [2023]
Acceptance and commitment therapy for fatigue interference in advanced gastrointestinal cancer and caregiver burden: protocol of a pilot randomized controlled trial. [2021]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security